US Stock MarketDetailed Quotes

NBRVF Nabriva Therapeutics PLC

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayClose Jan 2 16:00 ET
3.23Market Cap0.00P/E (TTM)

Nabriva Therapeutics PLC Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
103.92%511K
64.60%-5.62M
38.36%-36.71M
73.44%-1.63M
53.34%-6.18M
29.80%-13.04M
26.62%-15.87M
16.51%-59.56M
54.22%-6.12M
-5.11%-13.24M
Net income from continuing operations
-8.92%-12.06M
26.39%-8.7M
-15.64%-57.19M
-74.37%-22.78M
-8.09%-11.51M
5.79%-11.07M
15.46%-11.82M
28.83%-49.45M
26.75%-13.06M
17.75%-10.65M
Depreciation and amortization
-76.62%18K
-73.08%21K
-65.93%217K
-70.93%25K
-54.88%37K
-61.69%77K
-70.90%78K
-22.32%637K
-64.90%86K
-57.95%82K
Other non cash items
211.46%175K
37.97%367K
454.38%4.56M
925.65%4.32M
106.35%130K
-139.65%-157K
558.62%266K
9.89%822K
-12.47%421K
186.36%63K
Change In working capital
314.11%4.75M
131.42%1.7M
192.43%13.73M
194.40%16.68M
233.07%4.67M
73.05%-2.22M
38.53%-5.4M
-30.43%-14.86M
103.01%5.66M
-242.87%-3.51M
-Change in receivables
268.92%5.05M
-267.83%-3.86M
211.06%9.02M
140.26%6.57M
23.95%3.14M
65.80%-2.99M
149.48%2.3M
-37.88%-8.12M
203.21%2.74M
25,200.00%2.53M
-Change in inventory
1,442.27%1.5M
157.79%649K
155.64%4.83M
614.27%7.66M
67.12%-1.8M
108.52%97K
64.36%-1.12M
-68.96%-8.69M
5,460.00%1.07M
-800.82%-5.47M
-Change in payables and accrued expense
-327.09%-1.79M
180.98%5.03M
-87.07%326K
38.27%2.55M
959.95%3.2M
-56.57%790K
-708.59%-6.21M
325.29%2.52M
-59.58%1.84M
-39.85%-372K
-Change in other current assets
--0
-200.00%-1K
120.00%2K
---1K
--1K
-66.67%1K
107.69%1K
-225.00%-10K
--0
--0
-Change in other current liabilities
132.73%127K
-1,007.14%-127K
----
----
----
---388K
106.93%14K
----
----
----
-Change in other working capital
----
----
21.59%-443K
-760.00%-99K
-19.40%-240K
--270K
---374K
-175.53%-565K
--15K
---201K
Cash from discontinued investing activities
Operating cash flow
103.92%511K
64.60%-5.62M
38.36%-36.71M
73.44%-1.63M
53.34%-6.18M
29.80%-13.04M
26.62%-15.87M
16.51%-59.56M
54.22%-6.12M
-5.11%-13.24M
Investing cash flow
Cash flow from continuing investing activities
56.90%-50K
91.67%-3K
-224.69%-263K
41.67%-7K
-104K
-327.45%-116K
70.00%-36K
70.44%-81K
29.41%-12K
0
Net PPE purchase and sale
--0
91.43%-3K
-744.00%-211K
-12.50%-9K
-10,400.00%-103K
-163.37%-64K
70.59%-35K
77.88%-25K
55.56%-8K
110.00%1K
Net other investing changes
----
----
7.14%-52K
150.00%2K
0.00%-1K
-4.00%-52K
0.00%-1K
65.22%-56K
-500.00%-4K
-200.00%-1K
Cash from discontinued investing activities
Investing cash flow
56.90%-50K
91.67%-3K
-224.69%-263K
41.67%-7K
---104K
-327.45%-116K
70.00%-36K
70.44%-81K
29.41%-12K
--0
Financing cash flow
Cash flow from continuing financing activities
0
-321.15%-4.85M
-97.21%1.85M
-130.82%-659K
-72.79%1.11M
-103.14%-792K
-93.72%2.19M
146.49%66.37M
-84.75%2.14M
9.02%4.07M
Net issuance payments of debt
--0
---4.85M
---2.92M
---998K
---974K
---949K
--0
--0
--0
--0
Net common stock issuance
--0
--0
-92.39%2.12M
--0
--77K
--403K
-93.55%1.64M
-47.79%27.91M
-82.97%2.45M
--0
Proceeds from stock option exercised by employees
----
----
---406K
--0
--0
----
----
--0
--0
--0
Net other financing activities
--0
-99.82%1K
-92.06%3.06M
209.00%339K
-50.76%2.01M
-99.37%160K
-94.18%551K
1,295.32%38.46M
69.66%-311K
32.64%4.07M
Cash from discontinued financing activities
Financing cash flow
--0
-321.15%-4.85M
-97.21%1.85M
-130.82%-659K
-72.79%1.11M
-103.14%-792K
-93.72%2.19M
146.49%66.37M
-84.75%2.14M
9.02%4.07M
Net cash flow
Beginning cash position
-94.34%1.92M
-73.79%12.54M
15.01%47.83M
-71.69%14.77M
-67.12%20.16M
-38.28%33.96M
15.01%47.83M
-51.87%41.59M
26.17%52.17M
22.91%61.32M
Current changes in cash
103.31%461K
23.62%-10.47M
-622.04%-35.12M
42.61%-2.29M
43.57%-5.17M
-308.07%-13.95M
-204.00%-13.71M
115.06%6.73M
-723.75%-3.99M
-3.36%-9.17M
Effect of exchange rate changes
-183.55%-127K
12.80%-143K
64.05%-174K
117.24%60K
-1,157.14%-222K
137.91%152K
-167.21%-164K
-245.71%-484K
13.43%-348K
-93.67%21K
End cash Position
-88.82%2.26M
-94.34%1.92M
-73.79%12.54M
-73.79%12.54M
-71.69%14.77M
-67.12%20.16M
-38.28%33.96M
15.01%47.83M
15.01%47.83M
26.17%52.17M
Free cash flow
103.90%511K
64.66%-5.62M
38.03%-36.92M
73.33%-1.63M
52.56%-6.28M
29.07%-13.1M
26.86%-15.91M
16.60%-59.58M
54.22%-6.13M
-5.02%-13.24M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 103.92%511K64.60%-5.62M38.36%-36.71M73.44%-1.63M53.34%-6.18M29.80%-13.04M26.62%-15.87M16.51%-59.56M54.22%-6.12M-5.11%-13.24M
Net income from continuing operations -8.92%-12.06M26.39%-8.7M-15.64%-57.19M-74.37%-22.78M-8.09%-11.51M5.79%-11.07M15.46%-11.82M28.83%-49.45M26.75%-13.06M17.75%-10.65M
Depreciation and amortization -76.62%18K-73.08%21K-65.93%217K-70.93%25K-54.88%37K-61.69%77K-70.90%78K-22.32%637K-64.90%86K-57.95%82K
Other non cash items 211.46%175K37.97%367K454.38%4.56M925.65%4.32M106.35%130K-139.65%-157K558.62%266K9.89%822K-12.47%421K186.36%63K
Change In working capital 314.11%4.75M131.42%1.7M192.43%13.73M194.40%16.68M233.07%4.67M73.05%-2.22M38.53%-5.4M-30.43%-14.86M103.01%5.66M-242.87%-3.51M
-Change in receivables 268.92%5.05M-267.83%-3.86M211.06%9.02M140.26%6.57M23.95%3.14M65.80%-2.99M149.48%2.3M-37.88%-8.12M203.21%2.74M25,200.00%2.53M
-Change in inventory 1,442.27%1.5M157.79%649K155.64%4.83M614.27%7.66M67.12%-1.8M108.52%97K64.36%-1.12M-68.96%-8.69M5,460.00%1.07M-800.82%-5.47M
-Change in payables and accrued expense -327.09%-1.79M180.98%5.03M-87.07%326K38.27%2.55M959.95%3.2M-56.57%790K-708.59%-6.21M325.29%2.52M-59.58%1.84M-39.85%-372K
-Change in other current assets --0-200.00%-1K120.00%2K---1K--1K-66.67%1K107.69%1K-225.00%-10K--0--0
-Change in other current liabilities 132.73%127K-1,007.14%-127K---------------388K106.93%14K------------
-Change in other working capital --------21.59%-443K-760.00%-99K-19.40%-240K--270K---374K-175.53%-565K--15K---201K
Cash from discontinued investing activities
Operating cash flow 103.92%511K64.60%-5.62M38.36%-36.71M73.44%-1.63M53.34%-6.18M29.80%-13.04M26.62%-15.87M16.51%-59.56M54.22%-6.12M-5.11%-13.24M
Investing cash flow
Cash flow from continuing investing activities 56.90%-50K91.67%-3K-224.69%-263K41.67%-7K-104K-327.45%-116K70.00%-36K70.44%-81K29.41%-12K0
Net PPE purchase and sale --091.43%-3K-744.00%-211K-12.50%-9K-10,400.00%-103K-163.37%-64K70.59%-35K77.88%-25K55.56%-8K110.00%1K
Net other investing changes --------7.14%-52K150.00%2K0.00%-1K-4.00%-52K0.00%-1K65.22%-56K-500.00%-4K-200.00%-1K
Cash from discontinued investing activities
Investing cash flow 56.90%-50K91.67%-3K-224.69%-263K41.67%-7K---104K-327.45%-116K70.00%-36K70.44%-81K29.41%-12K--0
Financing cash flow
Cash flow from continuing financing activities 0-321.15%-4.85M-97.21%1.85M-130.82%-659K-72.79%1.11M-103.14%-792K-93.72%2.19M146.49%66.37M-84.75%2.14M9.02%4.07M
Net issuance payments of debt --0---4.85M---2.92M---998K---974K---949K--0--0--0--0
Net common stock issuance --0--0-92.39%2.12M--0--77K--403K-93.55%1.64M-47.79%27.91M-82.97%2.45M--0
Proceeds from stock option exercised by employees -----------406K--0--0----------0--0--0
Net other financing activities --0-99.82%1K-92.06%3.06M209.00%339K-50.76%2.01M-99.37%160K-94.18%551K1,295.32%38.46M69.66%-311K32.64%4.07M
Cash from discontinued financing activities
Financing cash flow --0-321.15%-4.85M-97.21%1.85M-130.82%-659K-72.79%1.11M-103.14%-792K-93.72%2.19M146.49%66.37M-84.75%2.14M9.02%4.07M
Net cash flow
Beginning cash position -94.34%1.92M-73.79%12.54M15.01%47.83M-71.69%14.77M-67.12%20.16M-38.28%33.96M15.01%47.83M-51.87%41.59M26.17%52.17M22.91%61.32M
Current changes in cash 103.31%461K23.62%-10.47M-622.04%-35.12M42.61%-2.29M43.57%-5.17M-308.07%-13.95M-204.00%-13.71M115.06%6.73M-723.75%-3.99M-3.36%-9.17M
Effect of exchange rate changes -183.55%-127K12.80%-143K64.05%-174K117.24%60K-1,157.14%-222K137.91%152K-167.21%-164K-245.71%-484K13.43%-348K-93.67%21K
End cash Position -88.82%2.26M-94.34%1.92M-73.79%12.54M-73.79%12.54M-71.69%14.77M-67.12%20.16M-38.28%33.96M15.01%47.83M15.01%47.83M26.17%52.17M
Free cash flow 103.90%511K64.66%-5.62M38.03%-36.92M73.33%-1.63M52.56%-6.28M29.07%-13.1M26.86%-15.91M16.60%-59.58M54.22%-6.13M-5.02%-13.24M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Oracle
ORCL
+0.69%
Salesforce
CRM
+0.61%
Microsoft
MSFT
+0.52%
Cisco
CSCO
+0.46%
Broadcom
AVGO
+0.29%

Unlock the Full List